Technology Ventures & Partnerships
Technology Ventures and Partnerships is the technology commercialization arm of NYU. It promotes the development of technologies created at NYU Langone Health and across all NYU campuses.
Technology Ventures and Partnerships actively develops technologies in-house and helps find external partners that take on the creation of products. Our aim is to benefit the public while also providing resources to support NYU Langone’s research, education, and patient care missions.
NYU has a strong track record of cultivating an innovative environment that successfully moves research discoveries from the laboratory to the market, and it has consistently ranked among the top 10 universities for generating license income.
Technology Ventures and Partnerships comprises three units:
Industrial Liaison promotes the commercial development of NYU technologies into products. It does so by protecting intellectual property, pursuing its licensing to industry, and driving the creation of new startup companies. Industrial Liaison also facilitates research collaborations with industry partners.
Therapeutics Alliances facilitates the translation of pioneering, medically relevant research to productive drug discovery projects. It also fosters greater partnerships with biopharma and investors for new biotechnology startups.
Biomedical Entrepreneurship Program
The Biomedical Entrepreneurship Program helps accelerate the commercialization of research discoveries by training postdocs, graduate students, and clinicians to become successful entrepreneurs in the biomedical field.
Technology Ventures and Partnerships Leadership
Vice President, Technology Opportunities and Ventures
Assistant to Marc Sedam
Executive Director, Industrial Liaison/Technology Transfer
Sadhana Chitale, PhD, MBA
Senior Director, Life Sciences/Technology Transfer
Robert Fechter, MS, MBA
Director, IT/Physical Sciences
Shilpa Patel, JD, PhD
Director, Intellectual Property
Christopher Snyder, MS
Associate Director, Engineering Technology Transfer
Xinyan Huang, PhD
Assistant Director, Therapeutics Alliances